Search

Your search keyword '"Rivera-Luna, Roberto"' showing total 4 results
Start Over Author "Rivera-Luna, Roberto" Journal frontiers in oncology
4 results on '"Rivera-Luna, Roberto"'

1. Evidence of spatial clustering of childhood acute lymphoblastic leukemia cases in Greater Mexico City: report from the Mexican Inter-Institutional Group for the identification of the causes of childhood leukemia

Author

Duarte-Rodríguez, David Aldebarán, primary, Flores-Lujano, Janet, additional, McNally, Richard J. Q., additional, Pérez-Saldivar, María Luisa, additional, Jiménez-Hernández, Elva, additional, Martín-Trejo, Jorge Alfonso, additional, Espinoza-Hernández, Laura Eugenia, additional, Medina-Sanson, Aurora, additional, Paredes-Aguilera, Rogelio, additional, Merino-Pasaye, Laura Elizabeth, additional, Velázquez-Aviña, Martha Margarita, additional, Torres-Nava, José Refugio, additional, Espinosa-Elizondo, Rosa Martha, additional, Amador-Sánchez, Raquel, additional, Dosta-Herrera, Juan José, additional, Mondragón-García, Javier Anastacio, additional, González-Ulibarri, Juana Esther, additional, Martínez-Silva, Sofía Irene, additional, Espinoza-Anrubio, Gilberto, additional, Paz-Bribiesca, María Minerva, additional, Salcedo-Lozada, Perla, additional, Landa-García, Rodolfo Ángel, additional, Ramírez-Colorado, Rosario, additional, Hernández-Mora, Luis, additional, Santamaría-Ascencio, Marlene, additional, López-Loyola, Anselmo, additional, Godoy-Esquivel, Arturo Hermilo, additional, García-López, Luis Ramiro, additional, Anguiano-Ávalos, Alison Ireri, additional, Mora-Rico, Karina, additional, Castañeda-Echevarría, Alejandro, additional, Rodríguez-Jiménez, Roberto, additional, Cibrian-Cruz, José Alberto, additional, Solís-Labastida, Karina Anastacia, additional, Cárdenas-Cardos, Rocío, additional, López-Santiago, Norma, additional, Flores-Villegas, Luz Victoria, additional, Peñaloza-González, José Gabriel, additional, González-Ávila, Ana Itamar, additional, Sánchez-Ruiz, Martin, additional, Rivera-Luna, Roberto, additional, Rodríguez-Villalobos, Luis Rodolfo, additional, Hernández-Pérez, Francisco, additional, Olvera-Durán, Jaime Ángel, additional, García-Cortés, Luis Rey, additional, Mata-Rocha, Minerva, additional, Sepúlveda-Robles, Omar Alejandro, additional, Bekker-Méndez, Vilma Carolina, additional, Jiménez-Morales, Silvia, additional, Meléndez-Zajgla, Jorge, additional, Rosas-Vargas, Haydée, additional, Vega, Elizabeth, additional, Núñez-Enríquez, Juan Carlos, additional, and Mejía-Aranguré, Juan Manuel, additional

Published
2024
Full Text
View/download PDF

3. Impact of treatment and clinical characteristics on the survival of children with medulloblastoma in Mexico.

Author

Salceda-Rivera, Violeta, Tejocote-Romero, Isidoro, Osorio, Diana S., Bellido-Magaña, Rosalba, López-Facundo, Araceli, Anaya-Aguirre, Susana E., Ortiz-Morales, Daniel, Rivera-Luna, Roberto, Reyes-Gutiérrez, Evelyne, Rivera-Gómez, Rebeca, Velasco-Hidalgo, Liliana, Cortés-Alva, Deyanira, Lagarda-Arrechea, Sandra, Arreguín-González, Farina E., Benito-Reséndiz, Alma E., Chávez-Gallegos, Silvia, Pérez-Rivera, Eloy, Gaytán-Fernández, Guillermo J., Leon-Espitia, José A., and Domínguez-Sánchez, Jociela

Subjects
MEDULLOBLASTOMA, MIDDLE-income countries, PEDIATRIC oncology, LOW-income countries, OVERALL survival
Abstract

Introduction: Data on medulloblastoma outcomes and experiences in low- and middle-income countries, especially in Latin America, is limited. This study examines challenges in Mexico's healthcare system, focusing on assessing outcomes for children with medulloblastoma in a tertiary care setting. Methods: A retrospective analysis was conducted, involving 284 patients treated at 21 pediatric oncology centers in Mexico. Results: High-risk patients exhibited markedly lower event-free survival than standard-risk patients (43.5% vs. 78.3%, p<0.001). Influential factors on survival included anaplastic subtype (HR 2.4, p=0.003), metastatic disease (HR 1.9, p=0.001); residual tumor >1.5cm², and lower radiotherapy doses significantly impacted event-free survival (EFS) and overall survival (OS). Platinum-based chemotherapy showed better results compared to the ICE protocol in terms of OS and EFS, which was associated with higher toxicity. Patients under 3 years old displayed notably lower OS and EFS compared to older children (36.1% vs. 55.9%, p=0.01). [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results